Global Orthopedic Biomaterials Market Report 2023 to 2029: Players Include Arthrex, Bioventus, DePuy Synthes, Ferring Pharmaceuticals and Fidia Farmaceutici - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Orthopedic Biomaterials Market Size, Share and COVID-19 Impact Analysis 2023-2029 MedSuite Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more" report has been added to ResearchAndMarkets.com's offering.

In 2022, the global orthopedic biomaterials device market was valued at $5.6 billion. This is anticipated to increase over the forecast period at a CAGR of 3.4% to reach $7.1 billion.

The full report suite on the global market for orthopedic biomaterials includes bone graft substitutes, growth factors, cell therapy, hyaluronic acid viscosupplementation and cartilage repair (appendix only).

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Forecasts Until 2028, and Historical Data to 2018
• Market Drivers & Limiters for Each Segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Procedure Volumes
• Company Profiles, Product Portfolios and SWOT for Top Competitors
• COVID-19 Impact Analysis

GLOBAL ORTHOPEDIC BIOMATERIALS MARKET TRENDS

By the year 2030, elder persons are anticipated to outnumber children under the age of 10 (1.41 billion versus 1.35 billion), and, by 2050, projections indicate that there will be a greater number of persons aged 60 or over than adolescents aged 10-24 (2.1 billion versus 2.0 billion).

The aging of the population will significantly impact the orthopedic biomaterials device market, increasing the prevalence of bone diseases and the need for treating them. However, orthopedic biomaterials device markets were negatively impacted by COVID-19 in the short term due to mass cancellations and postponements of procedures across all countries.

GLOBAL ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS

Overall, within the Global orthopedic biomaterials market there are three leading competitors: Medtronic, DePuy Synthes, and Stryker. Medtronic has maintained a strong presence in the total orthopedic Biomaterials device market through a variety of characteristics including brand recognition, strong customer support and a large sales force.

The company held the largest share of the orthopedic bone graft substitute segment and dominated in the orthopedic growth factor market because of the success of its INFUSET product.

Key Topics Covered:

1. Executive summary

2. Impact of covid-19 on THE global Orthopedic Biomaterials DEVICE Market

2.1 Introduction

2.2 Regional Profiles

2.3 Analysis By Market Segment

2.3.1 Worst Case Scenario

2.3.2 Base Case Scenario

2.3.3 Best Case Scenario

3. Product Assessment

3.1 Introduction

3.2 Product Portfolios

3.3 Regulatory Issues and Recalls

3.4 Clinical Trials

4. Global Orthopedic Biomaterials Device Market Overview

4.1 Introduction

4.2 Market Overview & Trend Analysis

4.2.1 By Segment

4.2.2 By Region

4.3 Drivers and Limiters

4.3.1 Market Drivers

4.3.2 Market Limiters

4.4 Competitive Market Share Analysis

4.5 Mergers and Acquisitions

4.6 Company Profiles

4.6.1 Arthrex

4.6.2 Bioventus

4.6.3 DePuy Synthes

4.6.4 Ferring Pharmaceuticals

4.6.5 Fidia Farmaceutici

4.6.6 Harvest Technologies (Terumo BCT)

4.6.7 Medtronic

4.6.8 Musculoskeletal Transplant Foundation (MTF)

4.6.9 Surgalign Holdings (former RTI Surgical)

4.6.10 Sanofi

4.6.11 SeaSpine

4.6.12 Stryker

4.6.13 Vericel

4.6.14 Zimmer Biomet

4.7 SWOT Analysis

5. Orthopedic Bone Graft Substitute Market

5.1 Executive Summary

5.2 Introduction

5.3 Procedure Numbers

5.4 Market Overview

5.5 Market Analysis and Forecast

5.6 Unit Analysis

5.7 Drivers and Limiters

5.8 Competitive Market Share Analysis

6. Orthopedic Growth Factor Market

6.1 Executive Summary

6.2 Introduction

6.3 Procedure Numbers

6.4 Market Analysis and Forecast

6.5 Drivers and Limiters

6.6 Competitive Market Share Analysis

7. Orthopedic Cell Therapy Market

7.1 Executive Summary

7.2 Introduction

7.3 Procedure Numbers

7.4 Market Overview

7.5 Market Analysis and Forecast

7.6 Drivers and Limiters

7.7 Competitive Market Share Analysis

8. Hyaluronic Acid Viscosupplementation Market

8.1 Executive Summary

8.2 Introduction

8.3 Procedure Numbers

8.4 Market Overview

8.5 Market Analysis and Forecast

8.6 Drivers and Limiters

8.7 Competitive Market Share Analysis

9. Appendix: Orthopedic Cartilage Repair Market

10. Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/494d9f

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.